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Isolated left ventricular noncompaction (ILVNC) is a cardiomyopathy caused by intrauterine arrest of compaction of the
myocardial ﬁbres and meshwork, an important process in myocardial development. ILVNC is clinically accompanied by depressed
ventricular function, arrhythmias, and systemic embolization. We reported a case of ILVNC with basal ECG-tracing strongly
suggestive for type-2 Brugada syndrome (BrS). Up to now, this is the ﬁrst report investigating the association between ILVNC and
this particular ECG pattern.
1.Introduction
Isolated left ventricular noncompaction (ILVNC) is a rela-
tively newly deﬁned disorder of the endomyocardium char-
acterized by prominent ventricular trabeculations and deep
intertrabecular recesses [1]. Clinical manifestations include
a depressed left ventricular function, ventricular arrhyth-
mia, and systemic embolization [2, 3]. ILVNC has been
reported to be associated with several electrocardiographic
changes such as ST depression and ﬂat or negative T waves,
bundle branch block, and Wolﬀ-Parkinson-White (WPW)
syndrome [2–4]. To the best of our knowledge, Brugada
syndrome (BrS) has not been reported on previously. We
described a case of ILVNC with basal ECG tracing strongly
suggestive for type-2 BrS.
2.CaseReport
We reported the case of a 59-year-old man with basal ECG
tracingstronglysuggestivefortype-2BrSFigure1(c).H ehad
virtually no cardiac complaint or any medication before. On
physical examination, his heart rate was 70beats/min, blood
pressure was 130/80mmHg, and body temperature was
36.1◦C. Cardiopulmonary ﬁndings were normal. Haemato-
logical and biochemical tests were within normal limits.
Patient underwent a transthoracic echocardiogram
(TTE) that excluded arrhythmogenic right ventricular dys-
plasia, septal ischemia, ventricular aneurysm, and fast
repolarization and showed noncompaction areas in both
ventricles. This exam revealed the existence of two layers
of myocardium—a thin, compacted, epicardial layer and
a thick, noncompacted endocardial zone. The inner layer
consisted of multiple myocardial trabeculations and deep
intratrabecular recesses communicating with the left ven-
tricular cavity Figures 1(a) and 1(b). The ratio of systolic
thicknessofnoncompactedtocompactedmyocardiumlayers
was above 2.0 (N/C > 2.0). In the colour-Doppler the
deep intertrabecular recesses were ﬁlled with blood from the
ventricular cavity. This ﬁnding was conﬁrmed by nuclear
magnetic resonance (NMR).2 Cardiology Research and Practice
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Figure 1: (a) Four-chamber view showing left and right ventricular noncompaction. The inner noncompacted layer is thick and
hyperechogenic, and the outer is compacted and echolucent. This appearance is more markedly visible on the left ventricle’s lateral wall
and apex and on the right ventricle’s free wall and apex. (b) Left ventricular short axis view showing noncompacted areas in the apex.
(c) Type-2 ECG pattern with ST-segment elevation followed by a positive T wave in V1 and V2 consistent with Brugada syndrome.
The Holter ECG did not reveal any ipercinetic arrhyth-
mias but conﬁrmed ST-segment elevation in the right pre-
cordial leads (V1 and V2). Treadmill stress test according to
the Bruce protocol was normally sustained for BP and ECG
ischemicﬁndings.Duringtherecoveryphasethesaddleback-
type ST-segment elevation in V1 and V2 changed into a
coved-type ECG. The ventricular tachycardia elicited by the
ﬂecainide test was hemodynamically stable and normalized
without medication.
Based on the dynamic ECG changes (conversion from
saddleback- to coved-type ECG) and exercise-induced ven-
tricular tachycardia showing a left bundle branch block
pattern, a diagnosis of asymptomatic Brugada syndrome was
made.
The patient was sent to an arrhythmologic center for the
electrophysiological study.
3. Discussion
ILVNC is a rare congenital cardiomyopathy characterized
by excessively prominent trabecular meshwork and deep
intratrabecular recesses within the left ventricle, sometimes
also aﬀecting the right ventricle and interventricular septum
[4, 5]. The predominant clinical features are heart failure,
arrhythmias, embolic events, and sudden cardiac death
(SCD) [4]. By deﬁnition, ILVNC occurs in the absence
of other structural heart diseases. The gold standard for
the ILVNC diagnosis is the echocardiographic examination.
Because of an increasing awareness and interest in this dis-
order, and advances in echocardiographic imaging, reported
c a s e sh a v ei n c r e a s e d .
Although the etiology of ILVNC has not been fully
investigated, this disorder is thought to result from an
arrest in endomyocardial morphogenesis during the embry-
onic period [1]. During early embryonic life, the heart
is a loose interwoven meshwork of muscle ﬁbers. The
developing myocardium gradually condenses, and the large
spaces within the trabecular meshwork ﬂatten or disappear
[6].
The ECG of the previously reported patients with ILVNC
showed ST depression and ﬂat or negative T waves, bundle
branch block, WPW syndrome, and various patterns of
arrhythmia [2–4]. A high incidence of WPW syndromeCardiology Research and Practice 3
was found in children [4]. A basal ECG tracing strongly
suggestive for type-2 BrS accompanied by ILVNC has not yet
been reported.
Brugada syndrome (BrS; OMIM 601144) is an auto-
somal dominant arrhythmogenic pathology characterized
by syncope and SCD. This pathology, deﬁned by some
authors as “Idiopathic ventricular ﬁbrillation,” is actually
understood as a channelopathy probably consecutive to
mutations on SCN5A gene (3p21-23) encoding the cardiac
sodium channel’s α-subunit [7].
BrS manifests with syncope and cardiac arrest, typically
occurring in the third and fourth decade of life, and usually
at rest or during sleep. This eventuality called for an
aggressive therapeutic strategy in all patients with BrS and,
since no pharmacological treatment of proven eﬃcacy still
is available, it led to implantable cardioverter deﬁbrillator
(ICD) implants.
According to a recent consensus conference [8], BrS is
diagnosed in presence of the following diagnostic criteria.
(1) Type-1 ECG pattern with ST-segment elevation in
more than one right precordial lead, followed by a
negative T wave plus one of the following conditions
documented ventricular ﬁbrillation; self-terminating
polymorphicventriculartachycardia;afamilyhistory
of SCD (<45 years); coved-type ECGs in family
members; electrophysiological inducibility; syncope
or nocturnal agonal respiration.
(2) Appearance of type-2 ECG pattern with ST-segment
elevationinmorethanonerightprecordialleadupon
challenge with a sodium channel blockers (Flecainide
or Ajmaline), followed by a positive or biphasic T
wave that results in a saddleback conﬁguration.
(3) Appearance of type-3 ECG pattern characterized by
ST-segment elevation (≤1mm) in more than one
lead either with a coved-type or a saddleback mor-
phology, with conversion to type 1 after challenge
with a sodium channel blocker.
In their initial report on eight patients, Brugada et al.
emphasized the lack of structural cardiac abnormalities [9].
However, there is probably an overlap between Brugada
syndrome and other nosographic entities. It is reported
in the literature the association between the typical V1–
V3 segment elevation and right bundle branch block in
some patients with arrhythmogenic right ventricular car-
diomyopathy (ARVC; OMIM 107970) [10, 11]. Molecular
genetic studies identiﬁed ﬁve allelic variants cosegregating
with dilated cardiomyopathy (DCM) [12, 13]. Some authors
reported structural degeneration (ﬁbrosis) and apoptosis
during the analysis of myocardial biopsies of patients with
clinical diagnosis of Brugada syndrome and an SCN5A
mutation [14]. Taken as a whole, these studies suggest that
at least some SCN5A mutations manifest as both excitability
and structural derangement.
In the presented case, there was no conclusive proof of
the aetiology and the coexistence of the Brugada-type elec-
trocardiographic pattern and ILVNC might be coincidental.
However, the case is consistent with the consideration that
up to now none of the autopsies in Brugada patients turned
out to present a normal heart.
On a clinical basis, the possible coexistence of the
Brugada syndrome with structural myocardial alterations
should always be considered and it advocates the need of
careful echo and NMR studies on all BrS patients.
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